Showing results (501-510 of 508) with videos related to
Sort By:
Pageof 51
You have reached the last page of results.This site can display upto 508 results.
Malaria Journal|January 29, 2016
Comparison of the safety and efficacy of fixed-dose combination of arterolane maleate and piperaquine phosphate with chloroquine in acute, uncomplicated Plasmodium vivax malaria: a phase III, multicentric, open-label studyNeena Valecha, Deepali Savargaonkar, Bina Srivastava, et al.Iscience|March 16, 2021
Th1 skewed immune response of whole virion inactivated SARS CoV 2 vaccine and its safety evaluationBrunda Ganneru, Harsh Jogdand, Vijaya Kumar Daram, et al.Cancer Biology & Therapy|March 11, 2015
Calcium calmodulin dependent kinase kinase 2 - a novel therapeutic target for gastric adenocarcinomaYashwanth Subbannayya, Nazia Syed, Mustafa A Barbhuiya, et al.The Journal of the Association of Physicians of India|May 13, 2024
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and ConsensusAwadhesh Kumar Singh, Anoop Misra, Ashok Kumar Das, et al.Journal of Medicinal Chemistry|July 16, 2021
Discovery, Structure-Activity Relationships, and In Vivo Evaluation of Novel Aryl Amides as Brain Penetrant Adaptor Protein 2-Associated Kinase 1 (AAK1) Inhibitors for the Treatment of Neuropathic PainRichard A Hartz, Vijay T Ahuja, Susheel J Nara, et al.Genome Research|April 11, 2014
Predicting the virulence of MRSA from its genome sequenceMaisem Laabei, Mario Recker, Justine K Rudkin, et al.Journal of Medicinal Chemistry|February 16, 2022
Bicyclic Heterocyclic Replacement of an Aryl Amide Leading to Potent and Kinase-Selective Adaptor Protein 2-Associated Kinase 1 InhibitorsRichard A Hartz, Vijay T Ahuja, Susheel J Nara, et al.The Journal of Pharmacology and Experimental Therapeutics|September 29, 2017
Preclinical Characterization of (<i>R</i>)-3-((3<i>S</i>,4<i>S</i>)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate <i>N</i>-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive DisorderLinda J Bristow, Jyoti Gulia, Michael R Weed, et al.Pageof 51